Published in Arch Intern Med on July 01, 1985
Liver iron content determination by magnetic resonance imaging. World J Gastroenterol (2010) 1.21
Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. J Blood Med (2016) 0.76
Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington's disease models. J Mol Med (Berl) (2015) 0.75
The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes. Rev Bras Hematol Hemoter (2015) 0.75
Detecting anxiety and depression in general medical settings. BMJ (1988) 4.79
Platelets and shear stress. Blood (1996) 4.18
Somatic presentations of psychiatric illness in primary care setting. J Psychosom Res (1988) 3.50
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
Screening for psychiatric illness in general practice: the general practitioner versus the screening questionnaire. J R Coll Gen Pract (1987) 2.60
Fate of receptor and ligand during endocytosis of asialoglycoproteins by isolated hepatocytes. Proc Natl Acad Sci U S A (1982) 2.54
Intracellular dissociation of receptor-bound asialoglycoproteins in cultured hepatocytes. A pH-mediated nonlysosomal event. J Biol Chem (1983) 2.45
Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest (1984) 1.88
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation (2001) 1.88
The hypercoagulable states. Ann Intern Med (1985) 1.80
Comparison of two methods for assessing the removal of total organisms and pathogens from the skin. J Hyg (Lond) (1975) 1.76
Bleeding and thrombosis in the myeloproliferative disorders. Blood (1984) 1.74
Biochemical mechanisms of platelet activation. Blood (1989) 1.65
Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. Mol Cell Biol (1985) 1.61
The influence of social factors on common mental disorders. Destabilisation and restitution. Br J Psychiatry (1990) 1.51
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Dimensions of neuroses seen in primary-care settings. Psychol Med (1987) 1.46
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am J Cardiol (1994) 1.45
Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis (2001) 1.41
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest (1991) 1.41
Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res (1997) 1.39
In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. J Immunother (2001) 1.38
Identification of platelet receptors for prostaglandin I2 and D2. J Biol Chem (1979) 1.36
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation (1995) 1.35
Inhibition of platelet function by organic nitrate vasodilators. Blood (1980) 1.35
Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med (1981) 1.33
Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J Immunol (1987) 1.23
Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. J Clin Invest (1979) 1.23
Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol (1997) 1.21
Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. Br Med J (1976) 1.20
The prethrombotic state in cancer. Semin Oncol (1990) 1.19
Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation (2001) 1.19
Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest (1997) 1.19
Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood (1994) 1.19
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem Biophys Res Commun (2000) 1.19
Uremic bleeding: pathogenesis and therapy. Am J Med Sci (1998) 1.16
Reconstitution of the hepatic asialoglycoprotein receptor with phospholipid vesicles. Proc Natl Acad Sci U S A (1980) 1.13
Gentamicin- and silver-resistant pseudomonas in a burns unit. Br Med J (1979) 1.10
Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation. J Cell Biol (1981) 1.08
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol (1999) 1.07
Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. J Clin Invest (1984) 1.05
Low-molecular-weight heparin--an opportunity for home treatment of venous thrombosis. N Engl J Med (1996) 1.05
The use of a virtual three-dimensional model to evaluate the intraosseous space available for percutaneous screw fixation of acetabular fractures. J Bone Joint Surg Br (2005) 1.04
Second messenger function of phosphatidic acid in platelet activation. J Cell Physiol (1989) 1.04
The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells. Eur J Pharmacol (1992) 1.02
Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Am J Physiol (1993) 1.01
Thyroxine to 3,5,3'-triiodothyronine conversion by rat anterior pituitary and liver. Metabolism (1978) 0.97
Association of IgA multiple myeloma with pre-existing disease. Br J Haematol (1979) 0.97
Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med (1981) 0.96
Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J Clin Invest (1986) 0.96
Venous thrombosis as a chronic disease. N Engl J Med (1999) 0.96
Severe hemolytic anemia following mitral valve repair. Am Heart J (1989) 0.96
Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am (1990) 0.95
Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2000) 0.94
Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation (1988) 0.94
Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. Circ Res (1996) 0.93
Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle. FASEB J (2000) 0.93
Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. J Clin Pathol (1977) 0.93
Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood. Am J Med (1986) 0.92
Clonal separation of mature melanocytes from premelanocytes in a diploid human cell strain: spontaneous and induced pigmentation of premelanocytes. J Cell Sci (1985) 0.92
Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol (Noisy-le-grand) (2005) 0.92
Cure of hemophilia A by orthotopic liver transplantation. Gastroenterology (1988) 0.92
Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis. J Biol Chem (1997) 0.91
Carbon monoxide and vascular cell function (review). Int J Mol Med (1998) 0.91
Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med (1982) 0.91
Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest (1985) 0.91
The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer (1979) 0.90
Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression. Circ Res (1998) 0.90
Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. J Clin Invest (1985) 0.89
Raman and Fourier transform infrared spectroscopic studies of the interaction between glycophorin and dimyristoylphosphatidylcholine. Biochemistry (1981) 0.89
Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med (1985) 0.88
Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem (1993) 0.87
Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am J Physiol (1995) 0.87
Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester. J Cell Physiol (1990) 0.86
Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood (1978) 0.86
Endothelial cell adenylate cyclase: activation by catecholamines and prostaglandin I2+. Biochem Biophys Res Commun (1980) 0.86
Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol (1983) 0.85
Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 0.85
Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression. J Biol Chem (1996) 0.84
Divergent changes of thyroxine-5'-monodeiodination in rat pituitary and liver during maturation. Endocrinology (1980) 0.84
The role of platelets in thrombotic and vascular disease. Prog Cardiovasc Dis (1979) 0.84
Regulation of platelet arachidonic acid oxygenation by cyclic AMP. Blood (1980) 0.83
Desensitization of prostaglandin-activated platelet adenylate cyclase. Prostaglandins (1979) 0.83
Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosatetraenoic acid from arachidonic acid by blood vessels and cultured vascular endothelial cells. Thromb Res (1987) 0.83
Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endothelium. Blood (1981) 0.83
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation (1995) 0.83
cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol (1997) 0.82
PGE1 accelerates thrombolysis by tissue plasminogen activator. Blood (1989) 0.82
Somatic presentation of depressive illness in primary care. J R Coll Gen Pract Occas Pap (1987) 0.82
Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med (1986) 0.81
Turnover of eicosanoid precursor fatty acids among phospholipid classes and subclasses of cultured human umbilical vein endothelial cells. Biochem J (1989) 0.81
Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation. Bone Marrow Transplant (2001) 0.80
Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. Am J Physiol (1991) 0.80
Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions. Biorheology (1997) 0.80
A source isolator for infected patients. J Hyg (Lond) (1976) 0.79